{ "ok": true, "cik": "1294133", "ticker": "INGN", "name": "INOGEN, INC.", "filings": [ { "form": "8-K", "filed": "2026-09-30", "items": [ "1.01 Entry into a Material Definitive Agreement", "7.01 Regulation FD Disclosure", "8.01 Other Events", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/1294133/000129413326000037/0001294133-26-000037-index.htm" }, { "form": "10-Q", "filed": "2026-08-07", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/1294133/000129413326000034/0001294133-26-000034-index.htm" }, { "form": "8-K", "filed": "2026-08-06", "items": [ "2.02 Results of Operations and Financial Condition", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/1294133/000129413326000032/0001294133-26-000032-index.htm" }, { "form": "8-K", "filed": "2026-07-01", "items": [ "5.02 Departure or Election of Directors; Appointment of Officers", "7.01 Regulation FD Disclosure", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/1294133/000129413326000025/0001294133-26-000025-index.htm" }, { "form": "8-K", "filed": "2026-06-11", "items": [ "5.02 Departure or Election of Directors; Appointment of Officers", "5.07 Submission of Matters to a Vote of Security Holders", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/1294133/000129413326000021/0001294133-26-000021-index.htm" }, { "form": "10-Q", "filed": "2026-05-08", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/1294133/000129413326000016/0001294133-26-000016-index.htm" } ], "events12m": 10, "healthWatch": { "window": "last 12 months", "since": "2025-10-01", "signals": [ { "code": "5.02", "label": "Director or officer change", "count": 4, "latest": { "filed": "2026-07-01", "url": "https://www.sec.gov/Archives/edgar/data/1294133/000129413326000025/0001294133-26-000025-index.htm" } } ], "note": "Events the company itself filed with the SEC, most serious first. Shown beside the figures; they do not change the range or its receipt." }, "sources": { "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001294133.json", "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1294133" }, "license": "Figures as filed with the SEC. Card text CC BY 4.0, POPS4.", "notAdvice": "Reporting, not investment advice. No price targets and no trading recommendations.", "edgar": "🫧 Edgar looked up INOGEN, INC. ($INGN). Last filing: 8-K (1.01 Entry into a Material Definitive Agreement), 2026-09-30. 10 event filings (8-K) in the past twelve months.", "auditor": { "changes": [], "nonReliance": [], "restatedSince": null }, "metrics": { "fiscalYearEnd": "2025-12-31", "revenue": 348668000, "revenueGrowth1y": 0.03861425954334896, "revenueGrowthPerYear": -0.006583529534121224, "yearsOfData": 5, "operatingMargin": -0.08663542395631374, "operatingMarginPrior": -0.1266469072548815, "netMargin": -0.0652397122764349, "operatingCashFlow": -11216000, "capitalSpending": 2523000, "freeCashFlow": -13739000, "researchAndDevelopment": 19399000, "researchShareOfRevenue": 0.05563745454128283, "cash": 103729000, "longTermDebt": null, "longTermDebtChange": null, "revenueHistory": [ { "fiscalYearEnd": "2021-12-31", "revenue": 358003000 }, { "fiscalYearEnd": "2022-12-31", "revenue": 377241000 }, { "fiscalYearEnd": "2023-12-31", "revenue": 315660000 }, { "fiscalYearEnd": "2024-12-31", "revenue": 335705000 }, { "fiscalYearEnd": "2025-12-31", "revenue": 348668000 } ], "totalEquity": 192231000, "totalAssets": 298625000, "equityRatio": 0.6437203850983675, "returnOnEquity": -0.11833159063834657, "dividendsPaid": null, "payoutRatio": null, "dividendPerShare": null, "dividendYearsRising": null, "dividendCut": null, "priceBased": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown.", "earningsPerShare": -0.86, "sharesOutstanding": 26601652, "bookValuePerShare": 7.2262805332541005, "revenuePerShare": 13.107005534844227, "range80": { "low": 287954802.8912448, "high": 411213372.8301605, "baseline": 350882256.3080606, "n": 4309, "band": "b01", "bandLabel": "$100M–1B", "method": "v4.1", "credibility": 0.5, "growthYears": 4, "ownVolatility": 0.11482315878746654, "classVolatility": 0.1022985825903761, "volatility": 0.10874133941131071 }, "ifPaceHeld": { "low": 287954802.8912448, "high": 411213372.8301605 } }, "edgarette": "🔖 Exposure: revenue $348.7M (FY2025). Experience: revenue up 3.9% on the year, down 0.7% a year over 4 years; operating margin -8.7%, up from -12.7%. Soundness: equity 64.4% of assets, return on equity -11.8%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $288.0M and $411.2M next year (method v4.1: its own 4-year record of growth weighed at 50% against $100M–1B filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $263.1M to $451.6M. A statistical range, not company guidance. Against peers (13 filers, $50M+ revenue, orthopedic, prosthetic & surgical appliances & supplies): operating margin -8.7% against a 11.0% median; growth 3.9% against 7.5%.", "peers": { "sic": 3842, "sicDescription": "Orthopedic, Prosthetic & Surgical Appliances & Supplies", "calendarYear": 2025, "minRevenue": 50000000, "depth": 4, "group": "3842", "growth": [ 0.0753, 13 ], "opMargin": [ 0.1104, 13 ], "equityRatio": [ 0.6294, 12 ], "returnOnEquity": [ 0.1026, 12 ] }, "summary": "Inogen (INGN) grew revenue 3.9% in FY2025 to $349 million, operating margin -8.7% against a 11.0% median for orthopedic, prosthetic & surgical appliances & supplies, equity 64.4% of assets. Every figure is from the company’s own annual report filed with the SEC.", "chart": "
INOGEN, INC. against its own record and its peers
Operating marginPeer median 11.0%-8.7%Revenue, on the yearPeer median 7.5%3.9%Equity of assetsPeer median 62.9%64.4%Return on equityPeer median 10.3%-11.8%Gold tick: the median of 12–12 peers with $50M+ revenue in orthopedic, prosthetic & surgical appliances & supplies
", "chartHorizon": null, "backtest": { "tests": 10, "hits": 8, "rate": 0.8, "method": "v4", "byYear": { "2016": [ 1, 1 ], "2017": [ 1, 1 ], "2018": [ 1, 1 ], "2019": [ 0, 1 ], "2020": [ 0, 1 ], "2021": [ 1, 1 ], "2022": [ 1, 1 ], "2023": [ 1, 1 ], "2024": [ 1, 1 ], "2025": [ 1, 1 ] }, "note": "hindsight: the same credibility-weighted range on the company's own past years. Years 2018-2023 were used to fit or tune the method, so only 2025 outcomes are fully out of sample." }, "registry": { "logged": "2026-10-01T14:02:14.795Z", "hash": "7191db1d26fb96c0", "status": "open" }, "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.", "schema": "pops4.edgarette.card/1", "card": { "summary": "Inogen (INGN) grew revenue 3.9% in FY2025 to $349 million, operating margin -8.7% against a 11.0% median for orthopedic, prosthetic & surgical appliances & supplies, equity 64.4% of assets. Every figure is from the company’s own annual report filed with the SEC.", "exposure": { "fiscalYearEnd": "2025-12-31", "revenue": 348668000, "totalDebt": null, "cash": 103729000 }, "experience": { "revenueGrowth1y": 0.03861425954334896, "revenueGrowthPerYear": -0.006583529534121224, "operatingMargin": -0.08663542395631374, "operatingMarginPrior": -0.1266469072548815, "netMargin": -0.0652397122764349, "freeCashFlow": -13739000 }, "soundness": { "equityRatio": 0.6437203850983675, "returnOnEquity": -0.11833159063834657, "payoutRatio": null, "dividendPerShare": null, "dividendYearsRising": null, "dividendCut": null, "note": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown." }, "peers": { "sic": 3842, "sicDescription": "Orthopedic, Prosthetic & Surgical Appliances & Supplies", "calendarYear": 2025, "minRevenue": 50000000, "depth": 4, "group": "3842", "growth": [ 0.0753, 13 ], "opMargin": [ 0.1104, 13 ], "equityRatio": [ 0.6294, 12 ], "returnOnEquity": [ 0.1026, 12 ] }, "credibility": { "auditedYears": 5, "weight": "reasonable", "standard": "ASOP No. 25", "nonReliance": null, "auditorChange": null }, "healthWatch": { "window": "last 12 months", "since": "2025-10-01", "signals": [ { "code": "5.02", "label": "Director or officer change", "count": 4, "latest": { "filed": "2026-07-01", "url": "https://www.sec.gov/Archives/edgar/data/1294133/000129413326000025/0001294133-26-000025-index.htm" } } ], "note": "Events the company itself filed with the SEC, most serious first. Shown beside the figures; they do not change the range or its receipt." }, "range": { "low": 287954802.8912448, "high": 411213372.8301605, "baseline": 350882256.3080606, "coverage": 0.8, "method": "v4.1", "basis": "next fiscal year revenue: baseline = revenue x (1 + mean of one-year and three-year pace); width = the company's own volatility of yearly growth, credibility-weighted against its size class (Buhlmann), scaled to the 80% target on 2023 and tested on 2024", "calibratedOn": { "companyYears": 4309, "sizeBand": "$100M–1B", "fitYears": [ 2018, 2022 ], "tuneYear": 2023, "testYear": 2024, "coverageOnTestYear": 0.8341, "coverageAllYears": 0.6904374799277399, "stressCoverageAllYears": 0.819004992974709, "outcomeYears": [ 2019, 2025 ] }, "credibility": { "weightOnOwnRecord": 0.5, "growthYears": 4, "ownVolatility": 0.11482315878746654, "classVolatility": 0.1022985825903761, "pricedVolatility": 0.10874133941131071, "k": 3 }, "stress": { "low": 263133906.43768567, "high": 451634407.5100418, "basis": "the same range with widths set to hold 80% across 2018-2023, pandemic years included" }, "kind": "a statistical range, not company guidance; no view on the share price", "track": { "backtest": { "tests": 10, "hits": 8, "rate": 0.8, "method": "v4", "byYear": { "2016": [ 1, 1 ], "2017": [ 1, 1 ], "2018": [ 1, 1 ], "2019": [ 0, 1 ], "2020": [ 0, 1 ], "2021": [ 1, 1 ], "2022": [ 1, 1 ], "2023": [ 1, 1 ], "2024": [ 1, 1 ], "2025": [ 1, 1 ] }, "note": "hindsight: the same credibility-weighted range on the company's own past years. Years 2018-2023 were used to fit or tune the method, so only 2025 outcomes are fully out of sample." }, "registry": { "logged": "2026-10-01T14:02:14.795Z", "hash": "7191db1d26fb96c0", "status": "open" }, "scorecard": "https://www.pops4.com/boards/scorecard" } }, "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.", "sources": { "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001294133.json", "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1294133" }, "speedCash": { "fiscalYear": 2025, "cashConversion": -0.0322, "growth3y": -0.0259, "volatility": 0.1148, "paysDividend": false, "raisedDividend": false, "equityRatio": 0.6437, "quadrant": { "code": "ss", "label": "Slow and steady", "plain": "growing slower than its size class, with steadier revenue" }, "compass": { "code": "between", "inside": "Turns -3.2% of revenue into operating cash; revenue shrinking 2.6% a year over three years; no common dividend.", "outside": "Among $100M-1B companies: 19th percentile for cash, 26th for growth.", "emoji": "🌊", "label": "In between", "plain": "no clear cash pattern yet" }, "band": "$100M-1B", "cashPctInClass": 19, "growthPctInClass": 26, "source": "SEC XBRL frames, the company’s own audited figures; quadrant split at the median of its size class" }, "harbor": { "signs": [ { "key": "cash", "text": "operating cash flow was negative" } ], "rule": "Boat condition = number of warning signs: a serious warning filing in 12 months; liabilities over assets; slow and jumpy; negative operating cash; an 80% revenue range of ±25% or wider.", "level": 1, "name": "Sound ship", "plain": "one warning sign" }, "cashFlow": { "fiscalYearEnd": "2025-12-31", "operating": -11216000, "investing": -26209000, "financing": 24182000, "capitalSpending": 2523000, "free": -13739000, "trend": [ { "fiscalYearEnd": "2021-12-31", "operating": 23633000, "free": 18151000 }, { "fiscalYearEnd": "2022-12-31", "operating": -37532000, "free": -40869000 }, { "fiscalYearEnd": "2023-12-31", "operating": -3234000, "free": -8452000 }, { "fiscalYearEnd": "2024-12-31", "operating": 5914000, "free": 2554000 }, { "fiscalYearEnd": "2025-12-31", "operating": -11216000, "free": -13739000 } ], "note": "Annual, as filed in 10-K cash flow statements; negative investing/financing = cash going out (capital spending, buybacks, dividends, debt repaid)." }, "investments": { "fiscalYearEnd": "2025-12-31", "cash": 103729000, "shortTerm": 15848000, "longTerm": null, "equityHoldings": null, "totalAssets": 298625000, "ladder": null, "currentRatio": 3.12, "unrealizedGain": null, "unrealizedLoss": null, "note": "Balance-sheet cash and investment securities at fiscal year end, as filed; short-term = due or saleable within a year. Insurers and banks hold most of their book here." } }, "definitions": { "operatingMargin": "Operating income divided by revenue.", "netMargin": "Net income divided by revenue.", "freeCashFlow": "Cash from operations minus spending on property and equipment.", "researchShareOfRevenue": "Research and development expense for the year as a share of revenue, both as filed.", "equityRatio": "Shareholders equity as a share of total assets, both as filed. Higher means less of the company is owed to someone else.", "returnOnEquity": "Net income for the year against shareholders equity at year end.", "payoutRatio": "Dividends paid as a share of net income, in the year the cash went out.", "dividendYearsRising": "Consecutive years, counted back from the last on record, in which dividend per share rose. A fall ends the run and is reported as dividendCut.", "revenueGrowthPerYear": "Compound annual growth between the first and latest fiscal years shown.", "credibility": "How much weight a record deserves, in the actuarial sense (ASOP No. 25): more audited years, more weight.", "peers": "Medians of SEC filers with $50M+ revenue in the same industry code (SIC), narrowest group with at least 8 filers, calendar-year figures from SEC XBRL frames.", "backtest": "The same range method applied to the company's own past years, scored against what it actually reported next. Hindsight, and labelled so.", "healthWatch": "Distress-type events the company filed in the last 12 months (late-filing notices; 8-K items 1.03, 3.01, 2.04, 4.02, 4.01, 2.05, 2.06, 1.05, 5.02), each with its count and newest filing. Display only: they do not change the range or its receipt." }, "speedCash": { "fiscalYear": 2025, "cashConversion": -0.0322, "growth3y": -0.0259, "volatility": 0.1148, "paysDividend": false, "raisedDividend": false, "equityRatio": 0.6437, "quadrant": { "code": "ss", "label": "Slow and steady", "plain": "growing slower than its size class, with steadier revenue" }, "compass": { "code": "between", "inside": "Turns -3.2% of revenue into operating cash; revenue shrinking 2.6% a year over three years; no common dividend.", "outside": "Among $100M-1B companies: 19th percentile for cash, 26th for growth.", "emoji": "🌊", "label": "In between", "plain": "no clear cash pattern yet" }, "band": "$100M-1B", "cashPctInClass": 19, "growthPctInClass": 26, "source": "SEC XBRL frames, the company’s own audited figures; quadrant split at the median of its size class" }, "harbor": { "signs": [ { "key": "cash", "text": "operating cash flow was negative" } ], "rule": "Boat condition = number of warning signs: a serious warning filing in 12 months; liabilities over assets; slow and jumpy; negative operating cash; an 80% revenue range of ±25% or wider.", "level": 1, "name": "Sound ship", "plain": "one warning sign" }, "cashFlow": { "fiscalYearEnd": "2025-12-31", "operating": -11216000, "investing": -26209000, "financing": 24182000, "capitalSpending": 2523000, "free": -13739000, "trend": [ { "fiscalYearEnd": "2021-12-31", "operating": 23633000, "free": 18151000 }, { "fiscalYearEnd": "2022-12-31", "operating": -37532000, "free": -40869000 }, { "fiscalYearEnd": "2023-12-31", "operating": -3234000, "free": -8452000 }, { "fiscalYearEnd": "2024-12-31", "operating": 5914000, "free": 2554000 }, { "fiscalYearEnd": "2025-12-31", "operating": -11216000, "free": -13739000 } ], "note": "Annual, as filed in 10-K cash flow statements; negative investing/financing = cash going out (capital spending, buybacks, dividends, debt repaid)." }, "investments": { "fiscalYearEnd": "2025-12-31", "cash": 103729000, "shortTerm": 15848000, "longTerm": null, "equityHoldings": null, "totalAssets": 298625000, "ladder": null, "currentRatio": 3.12, "unrealizedGain": null, "unrealizedLoss": null, "note": "Balance-sheet cash and investment securities at fiscal year end, as filed; short-term = due or saleable within a year. Insurers and banks hold most of their book here." } }